Ex parte WALLACH et al. - Page 6



              Appeal No. 1999-0197                                                                                        
              Application 08/054,970                                                                                      

              claim 37 is directed to a method for identifying molecules which interact with TNF-R to                     
              modulate signal transduction.  The method comprises three steps:  (1) preparing a                           
              specified target peptide, (2) screening peptide libraries and/or broth of biological matter                 
              with the target peptide and identifying any molecules which bind to the target peptide and                  
              (3) screening any molecules identified in the second step for their ability to modulate signal              
              transduction of TNF-R to identify any molecule which tests positive for such signal                         
              transduction modulation.  As can be seen, claim 37 does not require that any molecule be                    
              actually identified.                                                                                        
                     The use claims however do require the presence and use of a molecule which                           
              interacts with a specified portion of TNF-R.  For example, claim 34 requires identification                 
              of a specific molecule and bringing that molecule into contact with a specified portion of                  
              TNF-R.                                                                                                      
                                                       Discussion                                                         
                     We start our analysis with the proposition that the examiner bears the  initial burden               
              of providing reasons why the supporting disclosure does not enable a claim.  In re                          
              Marzocchi, 439 F.2d 220, 223, 169 USPQ 367, 369 (CCPA 1971).  In reviewing the                              
              examiner’s statement of the rejection on pages 3-5 of the Answer, we find the examiner is                   
              concerned that the specification does not set forth “one example of an agent that binds to                  
              the TNF-R at any set of amino acids or those amino acids set forth in Claims [sic] or its                   
              effector protein.”  The examiner also states at page 4 of the Answer that “it is not                        
              predictable what the agent is that will stabilize the TNF-R or will bind an effector protein to             

                                                            6                                                             




Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007